BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37966242)

  • 1. Identification and impact on
    Forti F; Bertoli C; Cafora M; Gilardi S; Pistocchi A; Briani F
    Microbiol Spectr; 2023 Dec; 11(6):e0147723. PubMed ID: 37966242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
    Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential.
    Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L
    Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University.
    Würstle S; Lee A; Kortright KE; Winzig F; An W; Stanley GL; Rajagopalan G; Harris Z; Sun Y; Hu B; Blazanin M; Hajfathalian M; Bollyky PL; Turner PE; Koff JL; Chan BK
    Sci Rep; 2024 Feb; 14(1):2657. PubMed ID: 38302552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Bacteriophages in Removing Biofilms of
    Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
    Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
    [No Abstract]   [Full Text] [Related]  

  • 7. Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection.
    Ferry T; Kolenda C; Laurent F; Leboucher G; Merabischvilli M; Djebara S; Gustave CA; Perpoint T; Barrey C; Pirnay JP; Resch G
    Nat Commun; 2022 Jul; 13(1):4239. PubMed ID: 35869081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Phage Resistance in
    Markwitz P; Olszak T; Gula G; Kowalska M; Arabski M; Drulis-Kawa Z
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
    mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled bacteriophage therapy in a porcine model of pneumonia caused by Pseudomonas aeruginosa during mechanical ventilation.
    Guillon A; Pardessus J; L'Hostis G; Fevre C; Barc C; Dalloneau E; Jouan Y; Bodier-Montagutelli E; Perez Y; Thorey C; Mereghetti L; Cabrera M; Riou M; Vecellio L; Le Guellec S; Heuzé-Vourc'h N
    Br J Pharmacol; 2021 Sep; 178(18):3829-3842. PubMed ID: 33974271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in
    García-Cruz JC; Rebollar-Juarez X; Limones-Martinez A; Santos-Lopez CS; Toya S; Maeda T; Ceapă CD; Blasco L; Tomás M; Díaz-Velásquez CE; Vaca-Paniagua F; Díaz-Guerrero M; Cazares D; Cazares A; Hernández-Durán M; López-Jácome LE; Franco-Cendejas R; Husain FM; Khan A; Arshad M; Morales-Espinosa R; Fernández-Presas AM; Cadet F; Wood TK; García-Contreras R
    Front Cell Infect Microbiol; 2023; 13():1280265. PubMed ID: 38298921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Superinfective Pf Phage Prevents Dissemination of Pseudomonas aeruginosa in a Mouse Burn Model.
    Prokopczuk FI; Im H; Campos-Gomez J; Orihuela CJ; Martínez E
    mBio; 2023 Jun; 14(3):e0047223. PubMed ID: 37039641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa.
    Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M
    Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages.
    Fujiki J; Furusawa T; Munby M; Kawaguchi C; Matsuda Y; Shiokura Y; Nakamura K; Nakamura T; Sasaki M; Usui M; Iwasaki T; Gondaira S; Higuchi H; Sawa H; Tamura Y; Iwano H
    Microbiol Immunol; 2020 Nov; 64(11):778-782. PubMed ID: 32918505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
    Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
    Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant
    Racenis K; Lacis J; Rezevska D; Mukane L; Vilde A; Putnins I; Djebara S; Merabishvili M; Pirnay JP; Kalnina M; Petersons A; Stradins P; Maurins S; Kroica J
    Viruses; 2023 May; 15(5):. PubMed ID: 37243293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of
    Burke KA; Urick CD; Mzhavia N; Nikolich MP; Filippov AA
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo.
    Ashworth EA; Wright RCT; Shears RK; Wong JKL; Hassan A; Hall JPJ; Kadioglu A; Fothergill JL
    Nat Commun; 2024 Feb; 15(1):1547. PubMed ID: 38378698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phages, Fitness, Virulence, and Synergy: A Novel Approach for the Therapy of Infections Caused by Pseudomonas aeruginosa.
    Stratton CW
    J Infect Dis; 2017 Mar; 215(5):668-670. PubMed ID: 28007923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.